Effects of Cross-sex Hormone Treatment on Cardiac Function, Myocardial and Hepatic Fat Content

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

October 20, 2017

Primary Completion Date

October 20, 2027

Study Completion Date

October 20, 2028

Conditions
Gender Dysphoria
Interventions
DRUG

gender affirming hormone therapy

both groups are receiving gender-affirming hormone therapy; we do not compare the groups, but look at whether hormone therapy with testosterone or estrogen might have an effect on myocardial function, organ lipid content and subcutaneous to visceral fat ratio

Trial Locations (1)

1090

RECRUITING

Chiari Stoffwechselambulanz, Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER